Samuel Ropp's Insider Trades & SAST Disclosures
Samuel Ropp's most recent trade in Singular Genomics Systems Inc was a trade of 4,187 Restricted Stock Units done . Disclosure was reported to the exchange on March 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Samuel Ropp.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 4,187 | 50,250 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 4,187 | 16,750 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 4,188 | 12,563 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 4,188 | 54,437 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 4,188 | 62,812 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 4,188 | 4,188 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges